Landscapes / Targets
5-HT1A
4 drugs act on 5-HT1A, in 9 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs4
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Atypical antipsychotic |
AbbVie · Public ABBV |
Approved | 15 Dec 2026soonPhase 3 trial completes | ||
| Next date | 15 Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Schizophrenia, Depression and 1 more | ||||
| Open drug page | |||||
— |
Approved | 1 Aug 2027Phase 4 trial completes | |||
| Next date | 1 Aug 2027 · Phase 4 trial completes | ||||
| Also tested for | Lennox Gastaut Syndrome, Dravet Syndrome and 5 more | ||||
| Open drug page | |||||
— |
Takeda +1 |
Approved | 30 Sep 2029Phase 3 trial completes | ||
| Next date | 30 Sep 2029 · Phase 3 trial completes | ||||
| Also tested for | Major Depressive Disorder | ||||
| Open drug page | |||||
— |
Phase 3 | — | |||
| Also tested for | Recurrent Pericarditis | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 4 of 4 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026